|
1
|
Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
|
J Clin Oncol
|
2007
|
2.11
|
|
2
|
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
|
Int J Cancer
|
2004
|
1.50
|
|
3
|
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.
|
J Clin Oncol
|
2006
|
1.43
|
|
4
|
Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.
|
Brain Pathol
|
2004
|
1.29
|
|
5
|
Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
|
Int J Cancer
|
2002
|
1.11
|
|
6
|
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
|
J Natl Cancer Inst
|
2004
|
1.09
|
|
7
|
Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
|
Int J Cancer
|
2006
|
0.92
|
|
8
|
Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
|
J Neuropathol Exp Neurol
|
2002
|
0.90
|
|
9
|
Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas.
|
Int J Cancer
|
2004
|
0.82
|